Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트Flu Hospitalization Rate Week 18, 2026?
Flu Hospitalization Rate Week 18, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$17,846 거래량
$17,846 거래량
2026.05.15
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$17,846 거래량
$17,846 거래량
2026.05.15
<80
$1,606 거래량
No
80–85
$1,729 거래량
No
85–90
$8,496 거래량
Yes
90–95
$3,413 거래량
No
95–100
$1,787 거래량
No
100+
$815 거래량
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
마켓 개설일: May 8, 2026, 12:14 PM ET
거래량
$17,846종료일
2026.05.15마켓 개설일
May 8, 2026, 12:14 PM ETResolver
0x69c47De9D...결과 제안됨: No
이의 없음
최종 결과: No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
거래량
$17,846종료일
2026.05.15마켓 개설일
May 8, 2026, 12:14 PM ETResolver
0x69c47De9D...결과 제안됨: No
이의 없음
최종 결과: No
Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트
외부 링크에 주의하세요.
외부 링크에 주의하세요.
자주 묻는 질문